Increased oxidized low density lipoprotein associated with high ceruloplasmin activity in patients with active acromegaly

Clinical Endocrinology

Volumn 72, Issue 5, 2010, Pages 654-660

  Boero, L ^a   Cuniberti, L ^b   Magnani, N ^a   Manavela, M ^c   Yapur, V ^a   Bustos, M ^a   Gomez Rosso L ^a   Merono T ^a   Marziali, L ^b   Viale, L ^d   Evelson, P ^a   Negri, G ^a   Brites, F ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b FAVALORO UNIVERSITY   (Argentina)

^c HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^d Children's Hospital   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; ARYLDIALKYLPHOSPHATASE 1; BILIRUBIN; CERULOPLASMIN; CHOLESTEROL ESTER TRANSFER PROTEIN; ENDOTHELIN 1; GLUCOSE; GROWTH HORMONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MYELOPEROXIDASE; OXIDIZED LOW DENSITY LIPOPROTEIN; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 3; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; URIC ACID;

ACROMEGALY; ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; BODY HEIGHT; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; WAIST CIRCUMFERENCE;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ACROMEGALY; ADULT; AGED; AGED, 80 AND OVER; BILIRUBIN; BODY MASS INDEX; CERULOPLASMIN; ENDOTHELIN-1; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PEROXIDASE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES; URIC ACID;

EID: 77950198113     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2009.03685.x     Document Type: Article

References (44)

1. Colao, A., Baldelli, R., Marzullo, P. et al. (2000) Systemic hypertension and impaired glucose tolerance are independently correlated to the severity of the acromegalic cardiomyopathy. Journal of Clinical Endocrinology & Metabolism, 85, 193 199.
2. Colao, A. (2008) The GH/IGF axis and the cardiovascular system: clinical implications. Clinical Endocrinology, 69, 347 358.
3. Bengtsson, B.A., Edén, S., Ernest, I. et al. (1988) Epidemiology and long-term survival in acromegaly A study of 166 cases diagnosed between 1955 and 1984. Acta Medica Scandinavica, 223, 327 335.
4. Boero, L., Manavela, M., Gómez Rosso, L. et al. (2009) Alterations in biomarkers of cardiovascular disease in active acromegaly. Clinical Endocrinology, 70, 88 95.
5. Beentjes, A., van Tol, A., Sluiter, W.J. et al. (2000) Low plasma lecithin:cholesterol acyltransferase and lipid transfer protein activities in growth hormone deficient and acromegalic men: role in altered high density lipoproteins. Atherosclerosis, 153, 491 498.
6. Arosio, M., Sartore, G., Rossi, C.M. et al. (2000) LDL physical properties, lipoprotein and Lp(a) levels in acromegalic patients effects of octreotide therapy. Italian Multicenter Octreotide Study Group. Atherosclerosis, 151, 551 557.
7. Maffei, P., Sicolo, N. Plebani, M. (1999) Lipoprotein(a) in acromegaly. Annals of Internal Medicine, 130, 537 538.
8. Clayton, R.N. (2003) Cardiovascular function in acromegaly. Endocrine Reviews, 24, 272 277.
9. Sies, H. (1985) Oxidative stress: introductory remarks. In : H. Sies ed. Oxidative Stress. Academica Press, San Diego, 1 7.
10. Muller, G., Goettsch, C. Morawietz, H. (2007) Oxidative stress and endothelial dysfunction. Hamostaseologie, 27, 5 12.
11. Wolin, M.S., Gupte, S.A. Oeckler, R.A. (2002) Superoxide in the vascular system. Journal of Vascular Research, 39, 191 207.
12. Witztum, J.L. (1994) The oxidation hypothesis of atherosclerosis. Lancet, 344, 793 795.
13. Achmad, T.H., Winterscheidt, A., Lindemann, C. et al. (1997) Oxidized low density lipoprotein acts on endothelial cells in culture to enhance endothelin secretion and monocyte migration. Methods and Findings in Experimental and Clinical Pharmacology, 19, 153 159.
14. Fraley, A.E. Tsimikas, S. (2006) Clinical applications of circulating oxidized low-density lipoprotein biomarkers in cardiovascular disease. Current Opinion in Lipidology, 17, 502 509.
15. Malle, E., Marsche, G., Arnhold, J. et al. (2006) Modification of low-density lipoprotein by myeloperoxidase-derived oxidants and reagent hypochlorous acid. Biochimica et Biophysica Acta, 1761, 392 415.
16. Fox, P.L., Mazumder, B., Ehrenwald, E. et al. (2000) Ceruloplasmin and cardiovascular disease. Free Radical Biology & Medicine, 28, 1735 1744.
17. Carr, A.C., McCal, M.R. Frei, B. (2000) Oxidation of LDL by myeloperoxidase and reactive nitrogen species: reaction pathways and antioxidant protection. Arteriosclerosis, Thrombosis, and Vascular Biology, 20, 1716 1723.
18. Mukhopadhyay, C.K., Ehrenwald, E. Fox, P.L. (1996) Ceruloplasmin enhances smooth muscle cell- and endothelial cell-mediated low density lipoprotein oxidation by a superoxide-dependent mechanism. The Journal of Biological Chemistry, 271, 14773 14778.
19. Yarman, S., Ozden, T.A. Gökkuşu, C. (2003) The evaluation of lipid peroxidation and acute effect of octreotide on lipid peroxidation in patients with active acromegaly. Clinica Chimica Acta, 336, 45 48.
20. Brown-Borg, H.M., Rakoczy, S.G., Romanick, M.A. et al. (2003) Effects of growth hormone and insulin-like growth factor-1 on hepatocyte antioxidative enzymes. Experimental Biology and Medicine (Maywood, N.J.), 227, 94 104.
21. Assmann, G., Jabs, H.U., Kohnert, U. et al. (1984) LDL-holesterol determination in blood serum following precipitation of LDL with polyvinylsulfate. Clinica Cimica Acta, 140, 77 83.
22. 2+ precipitation procedure for quantitation of high-density- lipoprotein cholesterol. Clinical Chemistry, 28, 1379 1388.
23. Lagrost, L., Gandjini, H., Athias, A. et al. (1993) Influence of plasma cholesteryl ester transfer activity on the LDL and HDL distribution profiles in normolipidemic subjects. Arteriosclerosis, Thrombosis, and Vascular Biology, 13, 815 825.
24. Yagi, K. (1976) A simple fluorometric assay lipoperoxide in blood plasma. Biochemical Medicine, 15, 212 216.
25. Erel, O. (1998) Automated measurement of serum ferroxidase activity. Clinical Chemistry, 44, 2313 2319.
26. Yapur, V., Bustos, M.F., González, A.S. et al. (2007) Ceruloplasmin: measurement of serum ferroxidase activity. Acta Bioquimica Clínica Latinoamericana, 41, 347 351.
27. mancini, G., Carbonara, A.O. Heremans, G.F. (1965) Immunochemical quantitation of antigen by single radial immunodiffussion. Immunochemistry, 2, 235 254.
28. Lissi, E., Pascual, C. Del Castillo, M.D. (1992) Luminol luminescence induced by 2,2′-Azo-bis(2-amidinopropane) thermolysis. Free Radical Research Communications, 17, 299 311.
29. Misra, H. Fridovich, I. (1972) The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. The Journal of Biological Chemistry, 247, 3170 3175.
30. Henson, P.M., Zanolari, B., Schwartzman, N.A. et al. (1978) Intracellular control of human neutrophil secretion I. C5a-induced stimulus-specific desensitization and the effects of cytochalasin. Journal of Immunology (Baltimore, Md.), 121, 851 855.
31. Furlong, C.E., Richter, R.J., Seidel, S.L. et al. (1989) Spectrophotometric assays for the enzymatic hydrolysis of the active metabolites of chlorpyrifos and parathion by plasma paraoxonase/arylesterase. Analytical Biochemistry, 180, 242 247.
32. Blank, M.L., Hall, M.N., Cress, E.A. et al. (1983) Inactivation of 1-alkyl-2-acetylsn-glycero-3-phosphocholine by a plasmaacetylhydrolase: higher activities in hypertensive rats. Biochemical and Biophysical Research Communications, 113, 666 671.
33. Tsimikas, S., Glass, C. Steinberg, D. (2004) Lipoproteins, lipoprotein oxidation and atherogenesis. In : K.R. Chien ed. Molecular Basis of Cardiovascular Disease: A Companion to Braunwald's Heart Disease. W.B. Saunders Company, Philadelphia, 385 413.
34. Miller, R.C., Pelton, J.T. Huggins, J.P. (1993) Endothelins-from receptors to medicine. Trends in Pharmacological Sciences, 14, 54 60.
35. Tribble, D.L., Hol, l.L.G., Wood, P.D. et al. (1992) Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size. Atherosclerosis, 93, 189 199.
36. Itabe, H., Yamamoto, H., Imanaka, T. et al. (1996) Sensitive detection of oxidatively modified low density lipoprotein using a monoclonal antibody. Journal of Lipid Research, 37, 45 53.
37. Andersson, I.J., Johansson, M.E., Wickman, A. et al. (2006) Endothelial dysfunction in growth hormone transgenic mice. Clinical Science (London, England), 110, 217 225.
38. Mukhopadhyay, C.K. Fox, P.L. (1998) Ceruloplasmin copper induces oxidant damage by a redox process utilizing cell-derived superoxide as reductant. Biochemistry, 37, 14222 14229.
39. Daugherty, A., Dunn, J.L., Rateri, D.L. et al. (1994) Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. The Journal of Clinical Investigation, 94, 437 444.
40. Ylä-Herttuala, S., Rosenfeld, M.E., Parthasarathy, S. et al. (1990) Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions. Proceedings of the National Academy of Sciences of the United States of America, 87, 6959 6963.
41. Luoma, J.S., Strålin, P., Marklund, S.L. et al. (1998) Expression of extracellular SOD and iNOS in macrophages and smooth muscle cells in human and rabbit atherosclerotic lesions: colocalization with epitopes characteristic of oxidized LDL and peroxynitrite-modified proteins. Arteriosclerosis, Thrombosis, and Vascular Biology, 18, 157 167.
42. Segelmark, M., Persson, B., Hellmark, T. et al. (1997) Binding and inhibition of myeloperoxidase: a mayor function of ceruloplasmin? Clinical and Experimental Immunology, 108, 167 174.
43. Repetto, M., Reides, C., Gomez Carretero, M.L. et al. (1996) Oxidative stress in blood of HIV infected patients. Clinica Chimica Acta, 255, 107 117.
44. Gatto, E.M., Carreras, M.C., Pargament, G.A. et al. (1996) Neutrophil function, nitric oxide and blood oxidative stress in Parkinson's disease. Movement Disorders, 11, 261 267.